Unit 1 Day 5 Flashcards

1
Q

Major Symptoms Associated with Heart Failure

A
  • dec. cardiac output = -fatigue, sleepiness, wasting, reduced urine output
  • inc. pulmonary venous pressure = dyspnea, orthopnea, paroxysmal nocturnal dyspnea
  • inc. central venous pressure = edema, ascites
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

NYHA Function Classifications

A
-based on what people can do functionally
1 = asymptomatic
2= can walk up stairs with few symptoms
3= walk up stairs with symptoms
4 = symptomatic at rest
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Signs of Low Flow

A
  • cool extremities
  • tachycardia
  • low pulse pressure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Signs of Inc. Left Sided Pressure

A
  • rales
  • hypoxia
  • tachypnea
  • sitting bolt upright
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Signs of Inc. Right Sided Pressure

A
  • edema
  • hepatic congestion/hepatomegaly
  • JVD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Heart Failure Tests and Imaging Studies

A
  • chest radiography (CXR)- enlarged cardiac silhouette, acute pulmonary edema
  • natriuretic peptides (BNP or NT-proBNP)- secreted by myocardium in response to ventricular stretch
  • EKG- no direct diagnosis of HF
  • cardiac imaging for LVEF- ultrasound, nuclear, MRI, CT
  • right heart catheterization- measures pressure in various areas
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ACE Inhibitors (Angiotensin Converting Enzyme)

A
  • meds in in -pril (lisinopril, enalapril, benazepril)
  • block conversion of angiotensin1 to angiotensin 2
  • effects: direct vasodilation, dec. aldosterone activation, salt/water excretion, most effective in sicker pts
  • side effects: hypotension, worsening renal function, cough, hyperkalemia, angioedema
  • drug interactions: lithium, NSAIDs, salt substitutes, loop diuretics, K+ spakring diuretics
  • contraindications: pregnancy, bilateral renal artery stenosis, renal failure, angioedema, hyperkalemia
  • antiremodeling
  • prevents ACE breakdown of bradykinin (BK is a vasodilator)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

ARBs (Angiotensin Receptor Blockers)

A
  • meds end in -sartan (valsartan, candesartan, losartan)
  • effect: block receptor of angiotensin 2, salt/water excretion, potassium retention
  • clinical use: equivalent to ACE1, ACE + ARB combo may provide added benefit, generally used when pts develop cough due to ACE
  • side effects: ARBs, do not produce cough, similar side effects to ACE (hypotension, worse renal function, hyperkalemia, angioedema)
  • contraindications: over-producers of uric acid, pregnancy, volume depletion, renal arterial stenosis, hyperkalemia
  • no difference between ACE and ARB in all cause mortality
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Beta Blockers

A
  • meds end in -olol (metoprolol, carvedilol, bisoprolol)
  • effects: antagonize effects of sympathetic system (B adrenergic blockage), dec. contractility, best for mild to mod sx of HF
  • side effects: negative inotrope (fluid retention, hypotension, dec. cardiac output), bronchoconstriction
  • good for HFrEF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Diuretics

A
  • reverses fluid retention (Na Loss)
  • most common HF therapy
  • can be use chronically or acutely
  • side effects- dehydration, hypokalemia, sulfa, tinnitis
  • good for HFrEF and HFpEF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Neurohormonal Antagonists if HFrEF

A
  • ACE inhibitors
  • ARBs
  • MRAs
  • beta blockers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Vasodilators

A
  • arterial vasodilation- dec. LV afterload, dec. cardiac work, dec. mitral regurg, dec preload and afterload
  • hydralazine/isosorbide dinitrate in HFrEF in pts of african descent (can cause drug induced lupus side effect)
  • vasodilation- dec. preload
  • nitro
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Electrical Therapies of HFrEF

A
  • Implanted cadioverter defibrillator (ICD)
  • Cardiac resynchronization therapy (CRT)
  • inc. contractility, HR, so inc. CO
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Positive Inotropic Agents

A
  • digoxin
  • dobutamine
  • milrinone
  • used acutely and chronically
  • inc. contractility
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Mineralocorticoid Receptor Antagonists (MRA)

A
  • spironolactone and eplerenone
  • effects: blcok mineralocorticoid receptor (ACE/ARB aldosterone block is incomplete), Na loss
  • side effects: hyperkalemia, gynecomastia (spiro)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Tx for Chronic HFrEF (LVEF <40%)

A
  • BB
  • ACE/ARB
  • aldosterone antagonist
  • hydralazine/ISDN
  • +/- digoxin
  • ICD/CRT
17
Q

Tx for Acute HFrEF (LVEF < 40%)

A
  • IV diuresis
  • nitrates (if BP allows)
  • CPAP/BiPAP (if SOB)
  • pressors (if dec. CO, shock)
18
Q

Tx for Chronic HFpEF (LVEF > 40%)

A
  • control risk factors (DM, HTN, obesity)

- control volume status (?)

19
Q

Tx for Acute HFpEF

A
  • IV diuresis
  • nitrates (if BP allows)
  • CPAP/BiPAP
20
Q

HF Prevention Goals

A
  • hypertension
  • diabetes
  • hyperlipidemia
  • physical inactivity
  • excessive OH intake
  • smoking
  • dietary sodium
21
Q

Digoxin

A
  • mechanism of action: blocks Na/K pump ATPase, inotrope (INC CONTRACTION), slows rate of SA node, SLOWED CONDUCTION of AV node (causes activation of the Na/Ca pathway and causes calcium to enter the cell) (prolongs phase 0 and phase 4)
  • inc. contraction in HFrEF, and is antiarrhythmic in supraventricular arrhythmias
  • metabolism: oral or IV administration, renally eliminated, 38 hr half life (steady state 7-10 days)
  • side effects/toxicity: hypokalemia, hypercalcemia, hypomagnesemia, nausea, vomiting, weakness, confusion, bradycardia, arrhythmia, visual changes
  • sometimes extreme toxicity includes severe arrhythmia, bradycardia, heart block unresponsive to atropine, inc. K+
  • drug-drug interactions: quinidine, verapimil, amniodarone, propafinone, itraconazole, macrolide antibiotics
  • reduces number of pts hospitalized
  • from foxglove plant
  • reverse toxicity w/ digoxin immune fab
22
Q

Dobutamine

A
  • mechanism of action: beta1 agonist to inc. contractility, slight peripheral vasodilation
  • metabolism: 2 min half life
  • side effects/toxicity: angina, arrhythmia, dysrhythmia
  • drug-drug interactions: beta 1 agonist- not helpful if also taking beta blockers
  • not recommended if hypotensive
23
Q

milrinone

A
  • mechanism of action: PDE (phosphodiesterase degrades cAMP) inhibitor, augments Ca utilization, moderate peripheral vasodilation
  • inotrope, vasodilator
  • metabolism: 1-3 hr half life
  • side effects/toxicity: hypotension, thrombocytopenia, tachycardia, arrhythmias, fever, inc. LFTs
  • drug-drug interactions: recommended if receiving beta blocker
24
Q

dopamine

A
  • mechanism of action: endogenous precursor of norepinephrine directly stimulates adrenergic receptors
  • causes inotropy
  • metabolism: dose dependent effect, continuous infusion via pump
  • proarrhythmic
  • side effects/toxicity: none listed
  • drug-drug interactions: none listed
25
Q

HFrEF

A

-systolic dysfunction

26
Q

neprilysin inhibitors

A
  • new
  • prodrug
  • inhibits neprolysin
  • neprilysin normally degrades BNP (BNP is good for tx in HF)
  • also blocks angiotensin 2 receptor
27
Q

aldosterone

A
  • activated by angiotensin 2
  • causes water retention
  • inc. HR
  • activates sympathetic nervous system